Functionalized congeners of P2Y1 receptor antagonists: 2-alkynyl (N)-methanocarba 2'-deoxyadenosine 3',5'-bisphosphate analogues and conjugation to a polyamidoamine (PAMAM) dendrimer carrier.

The P2Y(1) receptor is a prothrombotic G protein-coupled receptor (GPCR) activated by ADP. Preference for the North (N) ring conformation of the ribose moiety of adenine nucleotide 3',5'-bisphosphate antagonists of the P2Y(1) receptor was established by using a ring-constrained methanocarba (a bicyclo[3.1.0]hexane) ring as a ribose substitute. A series of covalently linkable N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphates containing extended 2-alkynyl chains was designed, and binding affinity at the human (h) P2Y(1) receptor determined. The chain of these functionalized congeners contained hydrophilic moieties, a reactive substituent, or biotin, linked via an amide. Variation of the chain length and position of an intermediate amide group revealed high affinity of carboxylic congener 8 (K(i) 23 nM) and extended amine congener 15 (K(i) 132 nM), both having a 2-(1-pentynoyl) group. A biotin conjugate 18 containing an extended epsilon-aminocaproyl spacer chain exhibited higher affinity than a shorter biotinylated analogue. Alternatively, click coupling of terminal alkynes of homologous 2-dialkynyl nucleotide derivatives to alkyl azido groups produced triazole derivatives that bound to the P2Y(1) receptor following deprotection of the bisphosphate groups. The preservation of receptor affinity of the functionalized congeners was consistent with new P2Y(1) receptor modeling and ligand docking. Attempted P2Y(1) antagonist conjugation to PAMAM dendrimer carriers by amide formation or palladium-catalyzed reaction between an alkyne on the dendrimer and a 2-iodopurine-derivatized nucleotide was unsuccessful. A dialkynyl intermediate containing the chain length favored in receptor binding was conjugated to an azide-derivatized dendrimer, and the conjugate inhibited ADP-promoted human platelet aggregation. This is the first example of attaching a strategically functionalized P2Y receptor antagonist to a PAMAM dendrimer to produce a multivalent conjugate exhibiting a desired biological effect, i.e., antithrombotic action.

[1]  K. Jacobson,et al.  Quantification of recombinant and platelet P2Y(1) receptors utilizing a [(125)I]-labeled high-affinity antagonist 2-iodo-N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([(125)I]MRS2500). , 2010, Pharmacological research.

[2]  Jacobson,et al.  Polyamidoamine (PAMAM) dendrimer conjugates of "clickable" agonists of the A3 adenosine receptor and coactivation of the P2Y14 receptor by a tethered nucleotide. , 2010, Bioconjugate chemistry.

[3]  K. Jacobson.  Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs). , 2009, Bioconjugate chemistry.

[4]  K. Jacobson,et al.  PEGylated dendritic unimolecular micelles as versatile carriers for ligands of G protein-coupled receptors. , 2009, Bioconjugate chemistry.

[5]  V. Serebruany,et al.  Novel Antiplatelet Agents in Development: Prasugrel, Ticagrelor, and Cangrelor and Beyond , 2009, American journal of therapeutics.

[6]  K. Jacobson,et al.  Enhanced potency of nucleotide-dendrimer conjugates as agonists of the P2Y14 receptor: multivalent effect in G protein-coupled receptor recognition. , 2009, Bioconjugate chemistry.

[7]  M. Brechbiel,et al.  Growing applications of "click chemistry" for bioconjugation in contemporary biomedical research. , 2009, Cancer biotherapy & radiopharmaceuticals.

[8]  Charles L. Brooks,et al.  Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 , 2009, Nature Reviews Drug Discovery.

[9]  H. Tozaki-Saitoh,et al.  P2Y1 receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL‐6 release in hippocampal cultures , 2009, Glia.

[10]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.

[11]  R. Borojevic,et al.  Changes in Intracellular Ca2+ Levels Induced by Cytokines and P2 Agonists Differentially Modulate Proliferation or Commitment with Macrophage Differentiation in Murine Hematopoietic Cells* , 2008, Journal of Biological Chemistry.

[12]  K. Jacobson,et al.  Enhanced A3 adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates , 2008, Journal of nanobiotechnology.

[13]  M. Trincavelli,et al.  Regulation of A1 adenosine receptor functioning induced by P2Y1 purinergic receptor activation in human astroglial cells , 2008, Journal of neuroscience research.

[14]  M. Freund,et al.  Reduced Atherosclerotic Lesions in P2Y1/Apolipoprotein E Double-Knockout Mice: The Contribution of Non–Hematopoietic-Derived P2Y1 Receptors , 2008, Circulation.

[15]  BéatriceHechler,et al.  Reduced Atherosclerotic Lesions in P2Y1/Apolipoprotein E Double-Knockout Mice , 2008 .

[16]  Stefano Costanzi,et al.  On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor. , 2008, Journal of medicinal chemistry.

[17]  K. Jacobson,et al.  Toward multivalent signaling across G protein-coupled receptors from poly(amidoamine) dendrimers. , 2008, Bioconjugate chemistry.

[18]  R. Stevens,et al.  GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function , 2007, Science.

[19]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[20]  N. Dale,et al.  Purine-mediated signalling triggers eye development , 2007, Nature.

[21]  G. Sancesario,et al.  P2Y1 receptor switches to neurons from glia in juvenile versus neonatal rat cerebellar cortex , 2007, BMC Developmental Biology.

[22]  K. Jacobson,et al.  P2Y1 antagonists: combining receptor-based modeling and QSAR for a quantitative prediction of the biological activity based on consensus scoring. , 2007, Journal of medicinal chemistry.

[23]  C. Nájera,et al.  The Sonogashira reaction: a booming methodology in synthetic organic chemistry. , 2007, Chemical reviews.

[24]  D. Tomalia,et al.  Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. , 2007, Biochemical Society transactions.

[25]  Eric A. Barnard,et al.  International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy , 2006, Pharmacological Reviews.

[26]  K. Jacobson,et al.  [32P]2‐iodo‐N6‐methyl‐(N)‐methanocarba‐2′‐deoxyadenosine‐3′,5′‐bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors , 2006, British journal of pharmacology.

[27]  K. Jacobson,et al.  MRS2500 [2-Iodo-N6-methyl-(N)-methanocarba-2′-deoxyadenosine-3′,5′-bisphosphate], a Potent, Selective, and Stable Antagonist of the Platelet P2Y1 Receptor with Strong Antithrombotic Activity in Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.

[28]  C. Gachet.  Regulation of platelet functions by P2 receptors. , 2006, Annual review of pharmacology and toxicology.

[29]  K. Jacobson,et al.  Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor. , 2004, Biochemical pharmacology.

[30]  T Kendall Harden,et al.  Nucleotide analogues containing 2-oxa-bicyclo[2.2.1]heptane and l-alpha-threofuranosyl ring systems: interactions with P2Y receptors. , 2004, Bioorganic & medicinal chemistry.

[31]  K. Jacobson,et al.  Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. , 2004, Journal of medicinal chemistry.

[32]  H. Kolb,et al.  The growing impact of click chemistry on drug discovery. , 2003, Drug discovery today.

[33]  K. Jacobson,et al.  2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists. , 2003, Journal of medicinal chemistry.

[34]  K. Jacobson,et al.  Quantitation of the P2Y(1) receptor with a high affinity radiolabeled antagonist. , 2002, Molecular pharmacology.

[35]  H. Moon,et al.  Enantioselective synthesis of bicyclo[3.1.0]hexane carbocyclic nucleosides via a lipase-catalyzed asymmetric acetylation. Characterization of an unusual acetal byproduct. , 2002, The Journal of organic chemistry.

[36]  E. Barnard,et al.  Adenosine Nucleotides Acting at the Human P2Y1Receptor Stimulate Mitogen-activated Protein Kinases and Induce Apoptosis* , 2001, The Journal of Biological Chemistry.

[37]  M. Freund,et al.  Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. , 2001, Circulation.

[38]  J P Cazenave,et al.  Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. , 1999, The Journal of clinical investigation.

[39]  G. Spalluto,et al.  A2A-adenosine receptor reserve for coronary vasodilation. , 1998, Circulation.

[40]  S. Kunapuli,et al.  Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  K. Jacobson,et al.  Competitive and selective antagonism of P2Y1 receptors by N6‐methyl 2′‐deoxyadenosine 3′,5′‐bisphosphate , 1998, British journal of pharmacology.

[42]  L. Belardinelli,et al.  Substituted 1,3-dipropylxanthines as irreversible antagonists of A1 adenosine receptors. , 1994, Journal of medicinal chemistry.

[43]  M. Inaba,et al.  EFFICIENT SYNTHESIS OF SECONDARY CARBOXAMIDES WITH ω-SUBSTITUTED ETHYL AND PROPYL GROUPS ON NITROGEN ATOM BY NUCLEOPHILIC RING OPENING OF CYCLIC IMIDATES , 1984 .

[44]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[45]  H. Hiemstra,et al.  CuI‐Catalyzed Alkyne–Azide “Click” Cycloadditions from a Mechanistic and Synthetic Perspective , 2005 .

[46]  J. Cazenave,et al.  Preparation of washed platelet suspensions from human and rodent blood. , 2004, Methods in molecular biology.

[47]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .